AstraZeneca likely to run new COVID-19 vaccine trial, CEO says, as questions emerge

  • 📰 smh
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 80%

Australia Headlines News

Australia Latest News,Australia Headlines

AstraZeneca is likely to conduct an additional global trial to assess the efficacy of its COVID-19 vaccine, according to the company's chief executive officer, after current studies raised questions over its level of protection.

AstraZeneca and its CEO are facing scrutiny as the drugmaker responds to growing confusion over the vaccine.

A day after the data was unveiled, the head of the US vaccine program known as Operation Warp Speed said that the regimen showing the higher level of effectiveness was tested in a younger population. He also said that the half-dose was given to some people because of an error in the quantity of vaccine put into some vials. None of those details were disclosed in AstraZeneca or Oxford's original statements.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

AstraZeneca and Oxford got caught p-hacking lol.

Why are the media peddling a vax for a virus that harms almost no one

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in AU

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

AstraZeneca likely to run new COVID-19 vaccine trial, CEO says, as questions emergeQuestions have been raised about the trial of AstraZeneca's potential COVID-19 vaccine after the company acknowledged a lower dosage was given to some trial participants in error. coronavirus covid19 I for 1 won't be in the front line if receiving this vaccine which seems or appears a Hit & Miss Adventure with Science.🙁
Source: theage - 🏆 8. / 77 Read more »

AstraZeneca likely to run 'additional' COVID-19 vaccine trial as tricky questions emergeAstraZeneca is likely to run an additional global trial to assess the efficacy of its COVID-19 vaccine, after questions emerged over the results from its late-stage study.
Source: SBSNews - 🏆 3. / 89 Read more »

Novavax trial shows COVID-19 strain differences, CSL promises earlier delivery of AstraZeneca jabsAustralia’s third coronavirus vaccine has delivered promising results in phase three trials but is showing to be less effective against the potent super-spreading UK and South African variants of the virus Dirty tricks in EU..
Source: smh - 🏆 6. / 80 Read more »

Novavax trial shows COVID-19 strain differences, CSL promises earlier delivery of AstraZeneca jabsAustralia’s third coronavirus vaccine has delivered promising results in phase three trials but is showing to be less effective against the potent super-spreading UK and South African variants of the virus. vaccine covid19 Get your facts right or do you want to mislead the people? Report the data as they are and don’t play around. No other company than Novavax $NVAX (and JNJ since last night, but really mixed) has clinical data on the variants. rachelclun BevanShields . Best in class!!!
Source: theage - 🏆 8. / 77 Read more »

First US case of COVID-19 variant found as highest number of COVID hospitalisations recordedThe first reported US case of the COVID-19 variant seen in the United Kingdom is discovered in Colorado, as states report 121,235 hospitalisations, and 1,491 deaths in the past 24 hours. Another win for diversity in the US.😎👍 UK mutation, South Africa mutation and in Australia the Trump mutation has seeded our most recent community 🦠 cluster. If you can call it the 'UK variant' or the 'South African Covid strain' then you can also call the original the China Virus.
Source: abcnews - 🏆 5. / 83 Read more »